Atopic Dermatitis Drugs Market Trends, Share, Size, Analysis 2019-2027

April 15, 2019

According to a new market research report launched by Inkwood Research, the Global Atopic dermatitis was valued nearly $4930 million in 2018 and is anticipated to reach $ 7770 million by 2026, growing at an estimated CAGR of 4.77% during the forecast period of 2019-2027. Browse 24 market data tables and 17 figures spread over 150 pages along with in-depth analysis on Global atopic dermatitis market by Route of Administration (ROA) (Topical, Oral, Injectable) by Drug Class (Topical Antibiotics, Topical Antihistamines, Topical Corticosteroids, Topical Moisturizers/emollients, Topical Calcineurin Inhibitors, Immunomodulators, Off-label Therapies, Systemic Agents, Pde-4 Inhibitor, Interleukin Inhibitor) by Geography

Spotlight

MedImpact Healthcare Systems, Inc.

MedImpact, an independent, trend-focused pharmacy benefit manager (PBM), is the nation’s largest privately held PBM, serving health plans, self-funded employers and government entities.

OTHER VIDEOS

Free flowing amorphous solid dispersions for enhanced drug solubility

video | March 9, 2022

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules....

Watch Now

Optimizing Outcomes Across the Pharma Value Chain Network

video | January 20, 2022

The pharma industry faces new challenges to be more agile and flexible in the effort to produce and deliver medicines to market faster. Digitalization will play a key role in helping companies optimize their value chain network. Hear from AspenTech's David Leitham as he touches on this trend and how Industrial AI solutions will help companies stay ahead....

Watch Now

How Billionaire Mark Cuban's Online Pharmacy Went From Pitch To Reality

video | February 2, 2022

Billionaire investor Mark Cuban launched an online pharmacy that offers more than 100 generic drugs at an affordable price with a goal of being “radically transparent” in its price negotiations with drug companies....

Watch Now

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

Spotlight

MedImpact Healthcare Systems, Inc.

MedImpact, an independent, trend-focused pharmacy benefit manager (PBM), is the nation’s largest privately held PBM, serving health plans, self-funded employers and government entities.

Events